COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX)

Q: What does CUSIP 19243B102 represent in this 13F holders report?

CUSIP 19243B102 is the security identifier for CGTX - COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held CGTX - COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share in Q1 2025?

48 institutional investors reported CGTX - COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share for Q1 2025. Use the holders table for investor-level position and value details.

CUSIP: 19243B102

Q1 2025 13F Holders as of 31 Mar 2025

Security type / class: Equity / Common Stock, par value $0.001 per share
Total 13F shares: 11,627,581
Total 13F value: $4,889,933
Share change: +541,491
SEC-reported price per share: $0.42
Number of holders: 48
Value change: +$37,435
Number of buys: 20
Number of sells: 16
Shares outstanding: 87,819,638

Security key

19243B102

Report period

Q1 2025

Institutions

Top holders

CGTX full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 COGNITION THERAPEUTICS INC SEC filings COGNITION THERAPEUTICS INC company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 19243B102

Newer quarter: Q3 2025

Recent filing periods:

Q3 2026 Q2 2026 Q1 2026 Q4 2025 Q3 2025

Ownership snapshot

Top reported holders of CGTX - COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Ogden CAP Associates, LLC

Disclosed value leader

BIOS Capital Management, LP

Comparable rows

0/15

Latest evidence

31 Dec 2024

3/4/5 13F Highest disclosed value: $4,207,800 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BIOS Capital Management, LP has the largest disclosed position value at $4.21M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BIOS Capital Management, LP's linked filing trail.

Disclosed position value Top 5

Ogden CAP Associates, LLC $2.32M

Bios Clinical Opportunity Fund, LP $525.1K

BIOS Capital Management, LP $4.21M

VANGUARD GROUP INC $868.9K

Mark H. Breedlove $432.7K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Ogden CAP Associates, LLC	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$2,320,896 2,210,377 shares	—	13 Oct 2021
Bios Clinical Opportunity Fund, LP	3/4/5 Director, 10%+ Owner 3/4/5	— denominator unverified	$525,100 500,095 shares	—	08 Nov 2023
BIOS Capital Management, LP	13F Company 13F	— denominator unverified	$4,207,800 6,000,000 shares	—	31 Dec 2024
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$868,936 1,239,567 shares	—	31 Dec 2024
Mark H. Breedlove	3/4/5 Director 3/4/5	— denominator unverified	$432,653 412,050 shares	—	13 Oct 2021
Sigma Planning Corp	13F Company 13F	— denominator unverified	$430,942 614,490 shares	—	31 Dec 2024

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

11,627,581

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2025 vs Q2 2026 Across Filers

Q2 2026 holders

Q1 2025 holders

Holder diff

-18

Investor	Q2 2026 Shares	Q1 2025 Shares	Share Diff	Share Chg %	Q2 2026 value	Q1 2025 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend